Lung Cancer
Docetaxel after chemoradiotherapy shows encouraging results
Published in Cancer Weekly, June 10th, 2003
The SWOG-9504 study, led by David R. Gandara, MD, of the Southwest Oncology Group (SWOG), found that nearly 40% of patients remained alive at the 3-year follow-up.
The median survival was 26 months and the progression-free survival was 16 months, all of which surpass the results seen in a prior SWOG study (SWOG-9019) published last year in the JCO, where identical concurrent chemoradiotherapy was followed by two additional cycles of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-06-10)
More Articles from Cancer Weekly
- Colorectal Cancer
Vaccine trial launched for previously untreated metastatic disease - Gene Profiling
Genomic tools identify profiles of gene activity underlying cancer - Breast Cancer
Scientists return to rat as biomedical research tool - Cancer Risk Factor
Obesity increases cancer mortality - Drug Delivery
Research suggests strategies for getting drugs to cancer cells - Gene Recombination
A new fusion gene uses vaccine mechanisms to halt kidney cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
